|
ITGA10 |
integrin subunit alpha 10 |
- Integrin cell surface interactions
- Integrin cell surface interactions
- CHL1 interactions
- Platelet Adhesion to exposed collagen
|
|
|
|
ITGA11 |
integrin subunit alpha 11 |
- Integrin cell surface interactions
- Integrin cell surface interactions
|
|
|
|
ITGA2 |
integrin subunit alpha 2 |
- Integrin cell surface interactions
- Integrin cell surface interactions
- Laminin interactions
- Laminin interactions
- Syndecan interactions
- ECM proteoglycans
- CHL1 interactions
- Platelet Adhesion to exposed collagen
- MET activates PTK2 signaling
- Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition
|
|
|
|
ITGA3 |
integrin subunit alpha 3 |
- Basigin interactions
- Integrin cell surface interactions
- Integrin cell surface interactions
- Laminin interactions
- MET activates PTK2 signaling
|
|
|
|
ITGA4 |
integrin subunit alpha 4 |
- Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
- Cell surface interactions at the vascular wall
- Integrin cell surface interactions
- Integrin cell surface interactions
- RUNX3 Regulates Immune Response and Cell Migration
- Potential therapeutics for SARS
|
- Natalizumab
- ATL1102
- CDP323
- R1295
- R411
- Tinzaparin
- Vedolizumab
- MK-0668
|
|
|
ITGA5 |
integrin subunit alpha 5 |
- Elastic fibre formation
- Fibronectin matrix formation
- Cell surface interactions at the vascular wall
- Integrin cell surface interactions
- Integrin cell surface interactions
- Signal transduction by L1
- RUNX2 regulates genes involved in cell migration
- GPER1 signaling
- Mechanical load activates signaling by PIEZO1 and integrins in osteocytes
- Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
- Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
|
- Resveratrol
- Tauroursodeoxycholic acid
|
|
|
ITGA6 |
integrin subunit alpha 6 |
- Assembly of collagen fibrils and other multimeric structures
- Basigin interactions
- Integrin cell surface interactions
- Integrin cell surface interactions
- Laminin interactions
- Laminin interactions
- Syndecan interactions
- Type I hemidesmosome assembly
- Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin
- Developmental Lineage of Mammary Gland Luminal Epithelial Cells
- Developmental Lineage of Mammary Gland Alveolar Cells
- Developmental Lineage of Mammary Gland Myoepithelial Cells
- Developmental Lineage of Mammary Stem Cells
|
|
- Epidermolysis bullosa, junctional, including: Epidermolysis bullosa, junctional, Herlitz type (JEB-H); Epidermolysis bullosa, junctional, non-Herlitz type (JEB-nH); Epidermolysis bullosa, junctional, with pyloric atresia (JEB-PA)
|
|
ITGA8 |
integrin subunit alpha 8 |
- Molecules associated with elastic fibres
- Integrin cell surface interactions
- Integrin cell surface interactions
- TGF-beta receptor signaling activates SMADs
- ECM proteoglycans
- Formation of the ureteric bud
|
|
|
|
ITGA9 |
integrin subunit alpha 9 |
- Integrin cell surface interactions
- Integrin cell surface interactions
- ECM proteoglycans
- Signal transduction by L1
|
|
- Congenital muscular dystrophies (CMD/MDC), including: Merosin-deficient CMD (MDC1A); Ullrich CMD (UCMD); Integrin alpha7-deficient CMD; CMD with joint hyperlaxity (CMDH); CMD with epidermolysis bullosa; Walker-Warburg syndrome (WWS); Muscle-eye-brain disease (MEB); Fukuyama CMD (FCMD); CMD with muscle hypertrophy (MDC1C); CMD with severe intellectual impairment and abnormal glycosylation (MDC1D); Rigid spine syndrome (RSS); LMNA-deficient CMD; CMD with respiratory failure and muscle hypertrophy (MDC1B); Bethlem myopathy
|
|
ITGAV |
integrin subunit alpha V |
- Cross-presentation of particulate exogenous antigens (phagosomes)
- Elastic fibre formation
- PECAM1 interactions
- Molecules associated with elastic fibres
- Integrin cell surface interactions
- Integrin cell surface interactions
- TGF-beta receptor signaling activates SMADs
- Laminin interactions
- Syndecan interactions
- Syndecan interactions
- ECM proteoglycans
- VEGFA-VEGFR2 Pathway
- Signal transduction by L1
- Neutrophil degranulation
- Mechanical load activates signaling by PIEZO1 and integrins in osteocytes
- Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
|
- Antithymocyte immunoglobulin (rabbit)
- Levothyroxine
- PLN-74809
|
|
|
ITGB1BP1 |
integrin subunit beta 1 binding protein 1 |
|
|
|
|
ITGB1BP2 |
integrin subunit beta 1 binding protein 2 |
|
|
|
|
LAMA1 |
laminin subunit alpha 1 |
- Laminin interactions
- Laminin interactions
- Non-integrin membrane-ECM interactions
- ECM proteoglycans
- L1CAM interactions
- MET activates PTK2 signaling
- Attachment of bacteria to epithelial cells
- Formation of the dystrophin-glycoprotein complex (DGC)
- Formation of the dystrophin-glycoprotein complex (DGC)
- Developmental Lineage of Pancreatic Ductal Cells
|
|
|
|
LAMTOR5 |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 |
- Macroautophagy
- MTOR signalling
- mTORC1-mediated signalling
- Energy dependent regulation of mTOR by LKB1-AMPK
- TP53 Regulates Metabolic Genes
- Regulation of PTEN gene transcription
- Amino acids regulate mTORC1
|
|
|
|
LGALS1 |
galectin 1 |
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Post-translational protein phosphorylation
|
- Mercaptoethanol
- Thiodigalactoside
- 1,4-Dithiothreitol
- Artenimol
- OTX-008
|
|
|
LGALS3BP |
galectin 3 binding protein |
|
|
|
|
LGALS8 |
galectin 8 |
|
|
|
|
MAP4K4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
- Oxidative Stress Induced Senescence
|
|
|
|
MET |
MET proto-oncogene, receptor tyrosine kinase |
- PIP3 activates AKT signaling
- Constitutive Signaling by Aberrant PI3K in Cancer
- Sema4D mediated inhibition of cell attachment and migration
- RAF/MAP kinase cascade
- MET Receptor Activation
- Negative regulation of MET activity
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- MET activates RAS signaling
- MET activates PI3K/AKT signaling
- MET activates PTPN11
- MET activates PTK2 signaling
- InlB-mediated entry of Listeria monocytogenes into host cell
- InlB-mediated entry of Listeria monocytogenes into host cell
- MET interacts with TNS proteins
- MET activates RAP1 and RAC1
- MET receptor recycling
- MET activates STAT3
- MECP2 regulates neuronal receptors and channels
- Drug-mediated inhibition of MET activation
- Regulation of MITF-M-dependent genes involved in cell cycle and proliferation
|
- Sunitinib
- K-252a
- SGX-523
- 1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide
- N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide
- 2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide
- N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide
- 3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol
- AMG-208
- 1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE
- Crizotinib
- Cabozantinib
- Capmatinib
- Tivozanib
- Fostamatinib
- Tivantinib
- Brigatinib
- Amuvatinib
- Tepotinib
- Amivantamab
|
- Cholangiocarcinoma
- Gastric cancer
- Renal cell carcinoma
|
|
NCKIPSD |
NCK interacting protein with SH3 domain |
- Regulation of actin dynamics for phagocytic cup formation
- Regulation of actin dynamics for phagocytic cup formation
- RHO GTPases Activate WASPs and WAVEs
- RHO GTPases Activate WASPs and WAVEs
- FCGR3A-mediated phagocytosis
- FCGR3A-mediated phagocytosis
|
|
|